CDIO - Cardio Diagnostics Holdings, Inc. Stock Price and Quote

CDIO [NASD]

Index	-	P/E	-	EPS (ttm)	-	Insider Own	19.80%	Shs Outstand	8.12M	Perf Week	136.46%
Market Cap	19.82M	Forward P/E	-	EPS next Y	-0.55	Insider Trans	0.00%	Shs Float	4.39M	Perf Month	110.19%
Income	-	PEG	-	EPS next Q	-0.09	Inst Own	55.60%	Short Float / Ratio	1.01% / 0.08	Perf Quarter	10.73%
Sales	0.00M	P/S	21994.56	EPS this Y	-	Inst Trans	-6.49%	Short Interest	0.04M	Perf Half Y	-77.12%
Book/sh	8.02	P/B	0.28	EPS next Y	36.80%	ROA	-	Target Price	8.00	Perf Year	-
Cash/sh	0.02	P/C	99.09	EPS next 5Y	-	ROE	-	52W Range	0.80 - 10.25	Perf YTD	114.15%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-77.85%	Beta	-
Dividend %	-	Quick Ratio	0.40	Sales past 5Y	-	Gross Margin	-	52W Low	184.96%	ATR	0.34
Employees	4	Current Ratio	0.40	Sales Q/Q	-	Oper. Margin	-	RSI (14)	76.52	Volatility	55.23% 22.82%
Optionable	No	Debt/Eq	0.01	EPS Q/Q	-	Profit Margin	-	Rel Volume	2.56	Prev Close	1.88
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	576.05K	Price	2.27
Recom	2.00	SMA20	92.78%	SMA50	66.47%	SMA200	-65.44%	Volume	1,475,651	Change	20.74%

Jan-05-23 08:00AM	Healing Sanctuary Clinic Partners With Cardio Diagnostics Holdings Inc to Offer the Epi+Gen CHD Test in their Medical Practice in Idaho Business Wire
Jan-04-23 04:15PM	Cardio Diagnostics Holdings Inc to Attend 41st Annual JP Morgan Healthcare Conference Business Wire
Dec-28-22 08:00AM	Houston Concierge Medicine Partners With Cardio Diagnostics to Offer the Epi+Gen CHD Test in Their Executive Health Program Business Wire
Nov-21-22 08:00AM	Cardio Diagnostics to Present at the Benchmark Companys Upcoming Discovery One-on-One Investor Conference Business Wire +40.34%
Nov-17-22 07:01AM	Cardio Diagnostics Named to Fast Companys Second Annual List of the Next Big Things in Tech Business Wire
04:15PM	Loading…
Nov-16-22 04:15PM	Cardio Diagnostics Holdings Inc Sponsors the Illinois Association of Medicaid Health Plans Annual Conference Business Wire -7.99%
Nov-14-22 08:13AM	Cardio Diagnostics Holdings Inc CEO Meesha Dogan, Accepted into Forbes Technology Council Business Wire +10.29%
Nov-08-22 07:12AM	Cardio Diagnostics Holdings Inc Sponsors Beckers Hospital Review 11th Annual Meeting - The CEO + CFO Roundtable Business Wire
Oct-26-22 08:30AM	Cardio Diagnostics Holdings, Inc. to List on Nasdaq Following Successful Business Combination with Mana Capital Acquisition Corp. Business Wire -36.23%

Cardio Diagnostics Holdings, Inc., a biotechnology company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks. The company was founded in 2017 and is headquartered in Chicago, Illinois.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience